• Stern, Ariel D. ‘Advancing Digital Health Applications: Priorities for Innovation in Real-World Evidence Generation’ 4 (2022): 7. https://doi.org/10.1016/S2589-7500(21)00292-2.
  • Kavaliunas, Andrius, Isis Lindfeldt, and Mattias Kyhlstedt. ‘Reply to a Commentary on Swedish Policy Analysis for Covid-19’. Health Policy and Technology, 16 July 2021, 100550. https://doi.org/10.1016/j.hlpt.2021.100550.
  • Kyhlstedt, Mattias, Rossella Di Bidino, and Sarah Wamala Andersson. ‘Do We Need a Decision Framework for Integrated Digital Health to Ensure Sustainable Healthcare?’ Health Policy and Technology, 27 April 2021, 100515. https://doi.org/10.1016/j.hlpt.2021.100515.
  • Kavaliunas, Andrius, Pauline Ocaya, Jim Mumper, Isis Lindfeldt, and Mattias Kyhlstedt. ‘Swedish Policy Analysis for Covid-19’. Health Policy and Technology, 29 August 2020. https://doi.org/10.1016/j.hlpt.2020.08.009.
  • Kyhlstedt, Mattias, and Sarah Wamala Andersson. ‘Diagnostic and Digital Solutions to Address the COVID-19 Pandemic: The Need for International Collaboration to Close the Gap’. Health Policy and Technology, 25 April 2020. https://doi.org/10.1016/j.hlpt.2020.04.010.
  • Velickovic, Vladica M., Emily McIlwaine, Rongrong Zhang, and Tim Spelman. ‘Adverse Events in Second- and Third-Line Treatments for Acute and Chronic Graft-versus-Host Disease: Systematic Review’. Therapeutic Advances in Hematology 11 (2020): 2040620720977039. https://doi.org/10.1177/2040620720977039.
  • Hill, Jonathan, Adrian Banning, Francesco Burzotta, Alaide Chieffo, Bernhard Schieffer, Andreas Schafer, Natalia MStelmaszuk-Zadykowicz, et al. ‘A Systematic Literature Review and Meta-Analysis of Impella Devices Used in Cardiogenic Shock and High Risk Percutaneous Coronary Interventions’. Interventional Cardiology 11, no. 1 (10 February 2019): 163. https://doi.org/10.4172/Interventional-Cardiology.1000624.
  • Borisenko, Oleg, Jochen Müller-Ehmsen, JoAnn Lindenfeld, Erik Rafflenbeul, and Christian Hamm. ‘An Early Analysis of Cost-Utility of Baroreflex Activation Therapy in Advanced Chronic Heart Failure in Germany’. BMC Cardiovascular Disorders 18, no. 1 (December 2018). https://doi.org/10.1186/s12872-018-0898-x.
  • Kaye, David M., Mark C. Petrie, Scott McKenzie, Gerd Hasenfuβ, Filip Malek, Martijn Post, Robert N. Doughty, et al. ‘Impact of an Interatrial Shunt Device on Survival and Heart Failure Hospitalization in Patients with Preserved Ejection Fraction: Inter-Atrial Shunt Device and Outcomes in HFpEF’. ESC Heart Failure, 11 October 2018. https://doi.org/10.1002/ehf2.12350.
  • Sanchez-Santos, Raquel, Esther Mariño Padin, Daniel Adam, Oleg Borisenko, Sergio Estevez Fernandez, Ester Carrera Dacosta, Sonia González Fernández, Juan Turnes Vazquez, Juan Carlos Ruiz de Adana, and Felipe de la Cruz Vigo. ‘Bariatric Surgery versus Conservative Management for Morbidly Obese Patients in Spain: A Cost-Effectiveness Analysis’. Expert Review of Pharmacoeconomics & Outcomes Research 18, no. 3 (June 2018): 305–14. https://doi.org/10.1080/14737167.2018.1407649.
  • Du, Xiaoyang, Adina Khamitova, Mattias Kyhlstedt, Sun Sun, and Mathilde Sengoelge. ‘Utilisation of Real-World Data from Heart Failure Registries in OECD Countries - A Systematic Review’. International Journal of Cardiology. Heart & Vasculature 19 (June 2018): 90–97. https://doi.org/10.1016/j.ijcha.2018.02.006.
  • Sun, Sun, Oleg Borisenko, Tim Spelman, and Ahmed R. Ahmed. ‘Patient Characteristics, Procedural and Safety Outcomes of Bariatric Surgery in England: A Retrospective Cohort Study—2006–2012’. Obesity Surgery 28, no. 4 (April 2018): 1098–1108. https://doi.org/10.1007/s11695-017-2978-x.
  • Borisenko, Oleg, Vasily Lukyanov, Isabelle Debergh, and Bruno Dillemans. ‘Cost-Effectiveness Analysis of Bariatric Surgery for Morbid Obesity in Belgium’. Journal of Medical Economics 21, no. 4 (April 2018): 365–73. https://doi.org/10.1080/13696998.2017.1419958.
  • Veličković, Vladica M., Oleg Borisenko, Mikael Svensson, Tim Spelman, and Uwe Siebert. ‘Congenital Heart Defect Repair with ADAPT Tissue Engineered Pericardium Scaffold: An Early-Stage Health Economic Model’. PloS One 13, no. 9 (2018): e0204643. https://doi.org/10.1371/journal.pone.0204643.
  • Borisenko, O, V Lukyanov, and A R Ahmed. ‘Cost–Utility Analysis of Bariatric Surgery’, 2018, 11.
  • Borisenko, Oleg, Oliver Mann, and Anna Duprée. ‘Cost-Utility Analysis of Bariatric Surgery Compared with Conventional Medical Management in Germany: A Decision Analytic Modeling’. BMC Surgery 17, no. 1 (December 2017). https://doi.org/10.1186/s12893-017-0284-0.
  • Bureau, Christophe, Danielle Adebayo, Mael Chalret de Rieu, Laure Elkrief, Dominique Valla, Markus Peck-Radosavljevic, Anne McCune, et al. ‘Alfapump® System vs. Large Volume Paracentesis for Refractory Ascites: A Multicenter Randomized Controlled Study’. Journal of Hepatology 67, no. 5 (November 2017): 940–49. https://doi.org/10.1016/j.jhep.2017.06.010.
  • Borisenko, Oleg, Vasily Lukyanov, Søren Paaske Johnsen, and Peter Funch-Jensen. ‘Cost Analysis of Bariatric Surgery in Denmark Made with a Decision-Analytic Model’. Danish Medical Journal 64, no. 8 (August 2017): A5401.
  • Andersson, Sarah Wamala, and Mattias Kyhlstedt. ‘Deriving More Value from RWE to Ensure Timely Access of Medicines by Patients’. Journal of Comparative Effectiveness Research 6, no. 5 (2017): 391–95. https://doi.org/10.2217/cer-2017-0030.
  • Lucchese, Marcello, Oleg Borisenko, Lorenzo Giovanni Mantovani, Paolo Angelo Cortesi, Giancarlo Cesana, Daniel Adam, Elisabeth Burdukova, Vasily Lukyanov, and Nicola Di Lorenzo. ‘Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling’. Obesity Facts 10, no. 3 (2017): 261–72. https://doi.org/10.1159/000475842.
  • Miikkulainen, Kaisa, Antonio Caruso, Oliver Mast, Rongrong Zhang, and Oleg Borisenko. ‘Systematic Literature Review of Use of Blood Glucose Monitoring in Phase III Clinical Studies of Insulin Analogs’. BMC Endocrine Disorders 16, no. 1 (December 2016). https://doi.org/10.1186/s12902-016-0102-1.
  • Zhang, R., O. Borisenko, I. Telegina, J. Hargreaves, A. R. Ahmed, R. Sanchez Santos, C. Pring, P. Funch-Jensen, B. Dillemans, and J. L. Hedenbro. ‘Systematic Review of Risk Prediction Models for Diabetes after Bariatric Surgery’. The British Journal of Surgery 103, no. 11 (October 2016): 1420–27. https://doi.org/10.1002/bjs.10255.
  • Borisenko, Oleg, Michael Haude, Uta C Hoppe, Tomasz Siminiak, Janusz Lipiecki, Steve L Goldberg, Nawzer Mehta, Omari V Bouknight, Staffan Bjessmo, and David G Reuter. ‘Cost-Utility Analysis of Percutaneous Mitral Valve Repair in Inoperable Patients with Functional Mitral Regurgitation in German Settings’. BMC Cardiovascular Disorders 15, no. 1 (December 2015). https://doi.org/10.1186/s12872-015-0039-8.
  • Borisenko, O, E Burdukova, J Hargreaves, D Adam, and P Funch-Jensen. ‘Cost-Utility of Bariatric Surgery In Belgium, Denmark, and Italy’. Value in Health 18, no. 7 (November 2015): A670–71. https://doi.org/10.1016/j.jval.2015.09.2453.
  • Borisenko, Oleg, Daniel Adam, Peter Funch-Jensen, Ahmed R. Ahmed, Rongrong Zhang, Zeynep Colpan, and Jan Hedenbro. ‘Bariatric Surgery Can Lead to Net Cost Savings to Health Care Systems: Results from a Comprehensive European Decision Analytic Model’. Obesity Surgery 25, no. 9 (September 2015): 1559–68. https://doi.org/10.1007/s11695-014-1567-5.
  • Borisenko, Oleg, Zeynep Colpan, Bruno Dillemans, Peter Funch-Jensen, Jan Hedenbro, and Ahmed R. Ahmed. ‘Clinical Indications, Utilization, and Funding of Bariatric Surgery in Europe’. Obesity Surgery 25, no. 8 (August 2015): 1408–16. https://doi.org/10.1007/s11695-014-1537-y.
  • Borisenko, Oleg, Daniel Adam, Peter Funch-Jensen, Ahmed R. Ahmed, Rongrong Zhang, Zeynep Colpan, and Jan Hedenbro. ‘Response to the Comment on “Bariatric Surgery Can Lead to Net Cost Savings to Health Care Systems: Results from a Comprehensive European Decision Analytic Model”’. Obesity Surgery 25, no. 7 (July 2015): 1256–57. https://doi.org/10.1007/s11695-015-1695-6.
  • Zhang, Rongrong, Farhang Modaresi, and Oleg Borisenko. ‘Health Economic Evaluations of Medical Devices in the People's Republic of China: A Systematic Literature Review’. ClinicoEconomics and Outcomes Research, April 2015, 195. https://doi.org/10.2147/CEOR.S78752.
  • Borisenko, Oleg, Gillian Wylie, John Payne, Staffan Bjessmo, Jon Smith, Richard Firmin, and Nizar Yonan. ‘The Cost Impact of Short-Term Ventricular Assist Devices and Extracorporeal Life Support Systems Therapies on the National Health Service in the UK’. Interactive CardioVascular and Thoracic Surgery 19, no. 1 (July 2014): 41–48. https://doi.org/10.1093/icvts/ivu078.
  • Borisenko, Oleg, Joachim Beige, Eric G. Lovett, Uta C. Hoppe, and Staffan Bjessmo. ‘Cost-Effectiveness of Barostim Therapy for the Treatment of Resistant Hypertension in European Settings’: Journal of Hypertension 32, no. 3 (March 2014): 681–92. https://doi.org/10.1097/HJH.0000000000000071.
  • Borisenko, Oleg, Gillian Wylie, John Payne, Staffan Bjessmo, Jon Smith, Nizar Yonan, and Richard Firmin. ‘Thoratec CentriMag for Temporary Treatment of Refractory Cardiogenic Shock or Severe Cardiopulmonary Insufficiency: A Systematic Literature Review and Meta-Analysis of Observational Studies’. ASAIO Journal 60, no. 5 (2014): 487–97. https://doi.org/10.1097/MAT.0000000000000117.
  • Roos, Johanna B., Sagar N. Doshi, Thomas Konorza, Igor Palacios, Ted Schreiber, Oleg V. Borisenko, and Jose P. S. Henriques. ‘The Cost-Effectiveness of a New Percutaneous Ventricular Assist Device for High-Risk PCI Patients: Mid-Stage Evaluation from the European Perspective’. Journal of Medical Economics 16, no. 3 (March 2013): 381–90. https://doi.org/10.3111/13696998.2012.762004.